Since LAT1 is the protein encoded by the SLC7A5 gene [22], we hypothesize that the higher TERT promoter mutation rate in neocortical gliomas may lead to increased LAT1 expression, which in turn enhances FET uptake and consequently increases metabolic activity. The gene discussed is SLC7A5; the disease is central nervous system cancer.